Argent Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $424K | Hold |
1,685
| – | – | 0.01% | 150 |
|
|
2026
Q1 | $366K | Sell |
1,685
-99
| -6% | -$22K | 0.01% | 144 |
|
|
2025
Q4 | $408K | Hold |
1,784
| – | – | 0.01% | 139 |
|
|
2025
Q3 | $413K | Sell |
1,784
-171
| -9% | -$34.8K | 0.01% | 132 |
|
|
2025
Q2 | $363K | Sell |
1,955
-26
| -1% | -$4.83K | 0.01% | 135 |
|
|
2025
Q1 | $415K | Sell |
1,981
-1,873
| -49% | -$364K | 0.01% | 133 |
|
|
2024
Q4 | $685K | Sell |
3,854
-1
| -0% | -$184 | 0.02% | 119 |
|
|
2024
Q3 | $761K | Sell |
3,855
-100,909
| -96% | -$18.8M | 0.02% | 107 |
|
|
2024
Q2 | $18M | Sell |
104,764
-371,028
| -78% | -$61.5M | 0.53% | 52 |
|
|
2024
Q1 | $86.6M | Sell |
475,792
-14,129
| -3% | -$2.44M | 2.53% | 15 |
|
|
2023
Q4 | $75.9M | Sell |
489,921
-8,632
| -2% | -$1.26M | 2.48% | 16 |
|
|
2023
Q3 | $74.3M | Sell |
498,553
-31,959
| -6% | -$4.69M | 2.64% | 12 |
|
|
2023
Q2 | $71.5M | Sell |
530,512
-6,523
| -1% | -$957K | 2.32% | 16 |
|
|
2023
Q1 | $85.6M | Sell |
537,035
-4,966
| -0.9% | -$759K | 2.97% | 9 |
|
|
2022
Q4 | $87.6M | Sell |
542,001
-2,809
| -0.5% | -$431K | 3.15% | 8 |
|
|
2022
Q3 | $73.1M | Sell |
544,810
-1,901
| -0.3% | -$273K | 2.87% | 11 |
|
|
2022
Q2 | $83.7M | Sell |
546,711
-8,964
| -2% | -$1.37M | 3.17% | 9 |
|
|
2022
Q1 | $90.1M | Sell |
555,675
-4,711
| -0.8% | -$684K | 2.84% | 11 |
|
|
2021
Q4 | $75.9M | Sell |
560,386
-2,584
| -0.5% | -$305K | 2.19% | 17 |
|
|
2021
Q3 | $60.7M | Sell |
562,970
-3,816
| -0.7% | -$436K | 1.92% | 20 |
|
|
2021
Q2 | $63.8M | Sell |
566,786
-7,505
| -1% | -$845K | 1.99% | 18 |
|
|
2021
Q1 | $62.1M | Sell |
574,291
-10,829
| -2% | -$1.16M | 2.06% | 19 |
|
|
2020
Q4 | $62.7M | Sell |
585,120
-25,311
| -4% | -$2.43M | 2.23% | 18 |
|
|
2020
Q3 | $53.5M | Sell |
610,431
-10,521
| -2% | -$991K | 2.04% | 18 |
|
|
2020
Q2 | $61M | Sell |
620,952
-45,409
| -7% | -$4M | 2.55% | 14 |
|
|
2020
Q1 | $50.8M | Buy |
666,361
+663,216
| +21,088% | +$56.5M | 2.39% | 13 |
|
|
2019
Q4 | $278K | Sell |
3,145
-1,392
| -31% | -$116K | 0.01% | 186 |
|
|
2019
Q3 | $344K | Sell |
4,537
-1,188
| -21% | -$81.4K | 0.01% | 183 |
|
|
2019
Q2 | $416K | Hold |
5,725
| – | – | 0.02% | 183 |
|
|
2019
Q1 | $461K | Sell |
5,725
-300
| -5% | -$24.5K | 0.02% | 180 |
|
|
2018
Q4 | $555K | Sell |
6,025
-825
| -12% | -$72.5K | 0.03% | 162 |
|
|
2018
Q3 | $648K | Buy |
6,850
+3,390
| +98% | +$321K | 0.02% | 174 |
|
|
2018
Q2 | $321K | Sell |
3,460
-49
| -1% | -$4.79K | 0.01% | 186 |
|
|
2018
Q1 | $332K | Sell |
3,509
-51
| -1% | -$5.6K | 0.01% | 189 |
|
|
2017
Q4 | $400K | Hold |
3,560
| – | – | 0.01% | 188 |
|
|
2017
Q3 | $316K | Buy |
3,560
+510
| +17% | +$38.8K | 0.01% | 192 |
|
|
2017
Q2 | $221K | Buy |
+3,050
| New | +$205K | 0.01% | 199 |
|
|
2016
Q1 | – | Sell |
-8,525
| Closed | -$505K | – | 204 |
|
|
2015
Q4 | $505K | Sell |
8,525
-261,396
| -97% | -$15.1M | 0.02% | 145 |
|
|
2015
Q3 | $14.7M | Buy |
269,921
+2,542
| +1% | +$165K | 0.73% | 40 |
|
|
2015
Q2 | $18M | Sell |
267,379
-717
| -0.3% | -$46.8K | 0.82% | 35 |
|
|
2015
Q1 | $15.7M | Buy |
268,096
+7,022
| +3% | +$424K | 0.71% | 39 |
|
|
2014
Q4 | $17.1M | Buy |
261,074
+38,894
| +18% | +$2.45M | 0.82% | 35 |
|
|
2014
Q3 | $12.8M | Sell |
222,180
-6,790
| -3% | -$377K | 0.7% | 39 |
|
|
2014
Q2 | $12.9M | Buy |
228,970
+1,470
| +0.6% | +$77.1K | 0.69% | 39 |
|
|
2014
Q1 | $11.7M | Buy |
227,500
+10,210
| +5% | +$516K | 0.64% | 43 |
|
|
2013
Q4 | $11.5M | Buy |
217,290
+2,210
| +1% | +$109K | 0.65% | 42 |
|
|
2013
Q3 | $9.62M | Buy |
215,080
+1,280
| +0.6% | +$56.7K | 0.59% | 42 |
|
|
2013
Q2 | $8.84M | Buy |
+213,800
| New | +$9.35M | 0.57% | 46 |
|
Other funds holding ABBV
Argent Capital Management's ABBV Position: Q2 2026 in Review
Argent Capital Management held its AbbVie (ABBV) position steady in Q2 2026 at 1,685 shares worth $424K. The position accounts for 0.01% of the portfolio, ranked #150.
Argent Capital Management first reported a position in ABBV in Q2 2013 and has held it in 48 quarters since. The position peaked at $90.1M in Q1 2022. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Argent Capital Management held 1,685 shares of AbbVie worth $424K as of Q2 2026.
- Argent Capital Management left its AbbVie share count unchanged in Q2 2026.
- AbbVie made up 0.01% of Argent Capital Management's portfolio in Q2 2026, its #150 holding.
- Argent Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 48 quarters since.
- Argent Capital Management's AbbVie position peaked at $90.1M in Q1 2022.
- 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Argent Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.